Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
pembrolizumab
×
Endocrine
×
Clear all
Filters
3
NCT03012620
2024-02-28
AcSé
UNICANCER
Phase 2
Completed
334 enrolled